Sabra Healthcare REIT Inc (SBRA) is overvalued and Ventas Inc (VTR) is overvalued.
Both trade above our estimate of their intrinsic value. VTR is the closer of the two: -234%, against -607% for SBRA.
Values as of the 22 Sept 2026 close.
Discounting its cash flows at 7.5% (average of 3 methods) values the shares at $2.80; the price of $19.81 is 607% above that value, and 81% of that value comes from beyond year five.
Leak Score 0/100 on 2 of 12 signals
Discounting its cash flows at 8.4% (average of 2 methods) values the shares at $26.01; the price of $86.86 is 234% above that value.
Leak Score 29/100 on 8 of 12 signals
| Metric | SBRA | VTR |
|---|---|---|
| Verdict | Overvalued | Overvalued |
| Price | $19.81 | $86.86 |
| Intrinsic value | $2.80 | $26.01 |
| Margin of safety | -607% | -234% |
| Leak Score | 0/100 (2/12) | 29/100 (8/12) |
| Market cap | $5.1B | $45.5B |
| Revenue growth, 5 years | 5.5% | 9.0% |
| Operating margin | 18.8% | 14.8% |
| Net margin | 7.6% | 4.1% |
| Return on equity | 2.4% | 2.0% |
| Debt to equity | 0.96 | 0.89 |
| P/E | 76.2x | 159.3x |
| Forward P/E | 25.9x | 92.2x |
| P/B | 1.8x | 3.0x |
| Dividend yield | 6.1% | 2.4% |